Cargando…
Development and Evaluation of a Leukemia Diagnosis System Using Deep Learning in Real Clinical Scenarios
Leukemia is the most common malignancy affecting children. The morphologic analysis of bone marrow smears is an important initial step for diagnosis. Recent publications demonstrated that artificial intelligence is able to classify blood cells but a long way from clinical use. A total of 1,732 bone...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264256/ https://www.ncbi.nlm.nih.gov/pubmed/34249819 http://dx.doi.org/10.3389/fped.2021.693676 |
_version_ | 1783719513338937344 |
---|---|
author | Zhou, Min Wu, Kefei Yu, Lisha Xu, Mengdi Yang, Junjun Shen, Qing Liu, Bo Shi, Lei Wu, Shuang Dong, Bin Wang, Hansong Yuan, Jiajun Shen, Shuhong Zhao, Liebin |
author_facet | Zhou, Min Wu, Kefei Yu, Lisha Xu, Mengdi Yang, Junjun Shen, Qing Liu, Bo Shi, Lei Wu, Shuang Dong, Bin Wang, Hansong Yuan, Jiajun Shen, Shuhong Zhao, Liebin |
author_sort | Zhou, Min |
collection | PubMed |
description | Leukemia is the most common malignancy affecting children. The morphologic analysis of bone marrow smears is an important initial step for diagnosis. Recent publications demonstrated that artificial intelligence is able to classify blood cells but a long way from clinical use. A total of 1,732 bone marrow images were used for the training of a convolutional neural network (CNN). New techniques of deep learning were integrated and an end-to-end leukemia diagnosis system was developed by using raw images without pre-processing. The system creatively imitated the workflow of a hematologist by detecting and excluding uncountable and crushed cells, then classifying and counting the remain cells to make a diagnosis. The performance of the CNN in classifying WBCs achieved an accuracy of 82.93%, precision of 86.07% and F1 score of 82.02%. And the performance in diagnosing acute lymphoid leukemia achieved an accuracy of 89%, sensitivity of 86% and specificity of 95%. The system also performs well at detecting the bone marrow metastasis of lymphoma and neuroblastoma, achieving an average accuracy of 82.93%. This is the first study which included a wider variety of cell types in leukemia diagnosis, and achieved a relatively high performance in real clinical scenarios. |
format | Online Article Text |
id | pubmed-8264256 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-82642562021-07-09 Development and Evaluation of a Leukemia Diagnosis System Using Deep Learning in Real Clinical Scenarios Zhou, Min Wu, Kefei Yu, Lisha Xu, Mengdi Yang, Junjun Shen, Qing Liu, Bo Shi, Lei Wu, Shuang Dong, Bin Wang, Hansong Yuan, Jiajun Shen, Shuhong Zhao, Liebin Front Pediatr Pediatrics Leukemia is the most common malignancy affecting children. The morphologic analysis of bone marrow smears is an important initial step for diagnosis. Recent publications demonstrated that artificial intelligence is able to classify blood cells but a long way from clinical use. A total of 1,732 bone marrow images were used for the training of a convolutional neural network (CNN). New techniques of deep learning were integrated and an end-to-end leukemia diagnosis system was developed by using raw images without pre-processing. The system creatively imitated the workflow of a hematologist by detecting and excluding uncountable and crushed cells, then classifying and counting the remain cells to make a diagnosis. The performance of the CNN in classifying WBCs achieved an accuracy of 82.93%, precision of 86.07% and F1 score of 82.02%. And the performance in diagnosing acute lymphoid leukemia achieved an accuracy of 89%, sensitivity of 86% and specificity of 95%. The system also performs well at detecting the bone marrow metastasis of lymphoma and neuroblastoma, achieving an average accuracy of 82.93%. This is the first study which included a wider variety of cell types in leukemia diagnosis, and achieved a relatively high performance in real clinical scenarios. Frontiers Media S.A. 2021-06-24 /pmc/articles/PMC8264256/ /pubmed/34249819 http://dx.doi.org/10.3389/fped.2021.693676 Text en Copyright © 2021 Zhou, Wu, Yu, Xu, Yang, Shen, Liu, Shi, Wu, Dong, Wang, Yuan, Shen and Zhao. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pediatrics Zhou, Min Wu, Kefei Yu, Lisha Xu, Mengdi Yang, Junjun Shen, Qing Liu, Bo Shi, Lei Wu, Shuang Dong, Bin Wang, Hansong Yuan, Jiajun Shen, Shuhong Zhao, Liebin Development and Evaluation of a Leukemia Diagnosis System Using Deep Learning in Real Clinical Scenarios |
title | Development and Evaluation of a Leukemia Diagnosis System Using Deep Learning in Real Clinical Scenarios |
title_full | Development and Evaluation of a Leukemia Diagnosis System Using Deep Learning in Real Clinical Scenarios |
title_fullStr | Development and Evaluation of a Leukemia Diagnosis System Using Deep Learning in Real Clinical Scenarios |
title_full_unstemmed | Development and Evaluation of a Leukemia Diagnosis System Using Deep Learning in Real Clinical Scenarios |
title_short | Development and Evaluation of a Leukemia Diagnosis System Using Deep Learning in Real Clinical Scenarios |
title_sort | development and evaluation of a leukemia diagnosis system using deep learning in real clinical scenarios |
topic | Pediatrics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264256/ https://www.ncbi.nlm.nih.gov/pubmed/34249819 http://dx.doi.org/10.3389/fped.2021.693676 |
work_keys_str_mv | AT zhoumin developmentandevaluationofaleukemiadiagnosissystemusingdeeplearninginrealclinicalscenarios AT wukefei developmentandevaluationofaleukemiadiagnosissystemusingdeeplearninginrealclinicalscenarios AT yulisha developmentandevaluationofaleukemiadiagnosissystemusingdeeplearninginrealclinicalscenarios AT xumengdi developmentandevaluationofaleukemiadiagnosissystemusingdeeplearninginrealclinicalscenarios AT yangjunjun developmentandevaluationofaleukemiadiagnosissystemusingdeeplearninginrealclinicalscenarios AT shenqing developmentandevaluationofaleukemiadiagnosissystemusingdeeplearninginrealclinicalscenarios AT liubo developmentandevaluationofaleukemiadiagnosissystemusingdeeplearninginrealclinicalscenarios AT shilei developmentandevaluationofaleukemiadiagnosissystemusingdeeplearninginrealclinicalscenarios AT wushuang developmentandevaluationofaleukemiadiagnosissystemusingdeeplearninginrealclinicalscenarios AT dongbin developmentandevaluationofaleukemiadiagnosissystemusingdeeplearninginrealclinicalscenarios AT wanghansong developmentandevaluationofaleukemiadiagnosissystemusingdeeplearninginrealclinicalscenarios AT yuanjiajun developmentandevaluationofaleukemiadiagnosissystemusingdeeplearninginrealclinicalscenarios AT shenshuhong developmentandevaluationofaleukemiadiagnosissystemusingdeeplearninginrealclinicalscenarios AT zhaoliebin developmentandevaluationofaleukemiadiagnosissystemusingdeeplearninginrealclinicalscenarios |